Search results for

Seven of 12 referendums to raise property tax revenue for local school districts passed in Indiana’s Tuesday general election.

Two new studies from Indiana Universitys Center for Evaluation and Education Policy show many Indiana public schools are seeing lower enrollment. The studies authors say fewer students often equates to decreases in funding.

Research shows even the threat of eviction can lead to higher rates of physical illness, high blood pressure and mental health issues and Indiana has one of the worst eviction rates in the country. Advocates say Indianas housing crisis can be traced to bad policy.

The results in Indianapolis’ City-County Council 2023 races played out with few surprises Tuesday night.

Voters in Ohio, Virginia and Kentucky signaled support for abortion rights, even where it wasn't directly on the ballot, more than a year after the Supreme Court rolled them back.

Political newcomer Brandon Sakbun has won the mayoral race for Terre Haute, defeating long-time mayor Duke Bennett.

Murders in Indianapolis are nearing record highs and last week, city officials released a pair of plans to curb crime, especially in the summer. Department of Public Safety says one concern is young people getting into trouble because they don't have anything else to do. But, as WFYI's Sam Klemet reports, just north of downtown, one woman has created a program that she believes can serve as a model for steering children in the right direction.

Across Israel, especially in the north, hospitals are setting up underground or fortified care facilities as fallout from war with Hamas intensifies fighting with militants in neighboring Lebanon.

Indiana University trustees will discuss plans to separate the world-famous Kinsey Institute from the university at meetings this week.

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of Ozempic. Short supply and high costs have limited access to both medications. The FDA approved the new drug for people considered obese or for those who are overweight and have a weight-related health condition.